The Association of Medicaid expansion with prescription drug utilization and expenditure among low-income participants with asthma
This study estimated the association between the 2014 Medicaid expansion and asthma-related prescription drug utilization and expenditures among low-income adult participants with asthma, including those with uncontrolled asthma, in the United States. In this national analysis, using a pooled datase...
Saved in:
| Published in: | The Journal of asthma Vol. ahead-of-print; no. ahead-of-print; pp. 1 - 10 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Taylor & Francis
02.11.2023
|
| Subjects: | |
| ISSN: | 0277-0903, 1532-4303, 1532-4303 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | This study estimated the association between the 2014 Medicaid expansion and asthma-related prescription drug utilization and expenditures among low-income adult participants with asthma, including those with uncontrolled asthma, in the United States.
In this national analysis, using a pooled dataset from 2007-2018 Medical Expenditure Panel Surveys (MEPS), regression discontinuity (D-RD) analyses estimated the association between Medicaid expansion and utilization of and expenditures for asthma-related prescription drugs among participants with asthma aged 26-64 with incomes below vs. at/above 138% of the federal poverty level (FPL). A sub-sample analysis was also conducted among participants with uncontrolled asthma. Utilization and expenditure outcomes were estimated using two-part models with logit as the first part and generalized linear models as the second part.
Utilization of and total cost for asthma-related prescription drugs increased by 1.89 fills (p < 0.001) and $306.59 (p < 0.001) among participants with asthma with income below 138% FPL after Medicaid expansion. The utilization and total cost of both short-acting bronchodilators and inhaled corticosteroids (ICSs) increased after Medicaid expansion among participants with asthma with incomes below 138% FPL. Among participants with uncontrolled asthma with incomes below 138% FPL, utilization and expenditures increased after Medicaid expansion for all asthma-related prescription drugs and short-acting bronchodilators.
Medicaid expansion was associated with increased utilization of and total expenditures for both quick-relief and preventive asthma medications among all low-income participants with asthma, but not with utilization of preventive medications among those with uncontrolled asthma. |
|---|---|
| AbstractList | This study estimated the association between the 2014 Medicaid expansion and asthma-related prescription drug utilization and expenditures among low-income adult participants with asthma, including those with uncontrolled asthma, in the United States.
In this national analysis, using a pooled dataset from 2007-2018 Medical Expenditure Panel Surveys (MEPS), regression discontinuity (D-RD) analyses estimated the association between Medicaid expansion and utilization of and expenditures for asthma-related prescription drugs among participants with asthma aged 26-64 with incomes below vs. at/above 138% of the federal poverty level (FPL). A sub-sample analysis was also conducted among participants with uncontrolled asthma. Utilization and expenditure outcomes were estimated using two-part models with logit as the first part and generalized linear models as the second part.
Utilization of and total cost for asthma-related prescription drugs increased by 1.89 fills (
< 0.001) and $306.59 (
< 0.001) among participants with asthma with income below 138% FPL after Medicaid expansion. The utilization and total cost of both short-acting bronchodilators and inhaled corticosteroids (ICSs) increased after Medicaid expansion among participants with asthma with incomes below 138% FPL. Among participants with uncontrolled asthma with incomes below 138% FPL, utilization and expenditures increased after Medicaid expansion for all asthma-related prescription drugs and short-acting bronchodilators.
Medicaid expansion was associated with increased utilization of and total expenditures for both quick-relief and preventive asthma medications among all low-income participants with asthma, but not with utilization of preventive medications among those with uncontrolled asthma. This study estimated the association between the 2014 Medicaid expansion and asthma-related prescription drug utilization and expenditures among low-income adult participants with asthma, including those with uncontrolled asthma, in the United States. In this national analysis, using a pooled dataset from 2007-2018 Medical Expenditure Panel Surveys (MEPS), regression discontinuity (D-RD) analyses estimated the association between Medicaid expansion and utilization of and expenditures for asthma-related prescription drugs among participants with asthma aged 26-64 with incomes below vs. at/above 138% of the federal poverty level (FPL). A sub-sample analysis was also conducted among participants with uncontrolled asthma. Utilization and expenditure outcomes were estimated using two-part models with logit as the first part and generalized linear models as the second part. Utilization of and total cost for asthma-related prescription drugs increased by 1.89 fills (p < 0.001) and $306.59 (p < 0.001) among participants with asthma with income below 138% FPL after Medicaid expansion. The utilization and total cost of both short-acting bronchodilators and inhaled corticosteroids (ICSs) increased after Medicaid expansion among participants with asthma with incomes below 138% FPL. Among participants with uncontrolled asthma with incomes below 138% FPL, utilization and expenditures increased after Medicaid expansion for all asthma-related prescription drugs and short-acting bronchodilators. Medicaid expansion was associated with increased utilization of and total expenditures for both quick-relief and preventive asthma medications among all low-income participants with asthma, but not with utilization of preventive medications among those with uncontrolled asthma. This study estimated the association between the 2014 Medicaid expansion and asthma-related prescription drug utilization and expenditures among low-income adult participants with asthma, including those with uncontrolled asthma, in the United States.OBJECTIVEThis study estimated the association between the 2014 Medicaid expansion and asthma-related prescription drug utilization and expenditures among low-income adult participants with asthma, including those with uncontrolled asthma, in the United States.In this national analysis, using a pooled dataset from 2007-2018 Medical Expenditure Panel Surveys (MEPS), regression discontinuity (D-RD) analyses estimated the association between Medicaid expansion and utilization of and expenditures for asthma-related prescription drugs among participants with asthma aged 26-64 with incomes below vs. at/above 138% of the federal poverty level (FPL). A sub-sample analysis was also conducted among participants with uncontrolled asthma. Utilization and expenditure outcomes were estimated using two-part models with logit as the first part and generalized linear models as the second part.METHODSIn this national analysis, using a pooled dataset from 2007-2018 Medical Expenditure Panel Surveys (MEPS), regression discontinuity (D-RD) analyses estimated the association between Medicaid expansion and utilization of and expenditures for asthma-related prescription drugs among participants with asthma aged 26-64 with incomes below vs. at/above 138% of the federal poverty level (FPL). A sub-sample analysis was also conducted among participants with uncontrolled asthma. Utilization and expenditure outcomes were estimated using two-part models with logit as the first part and generalized linear models as the second part.Utilization of and total cost for asthma-related prescription drugs increased by 1.89 fills (p < 0.001) and $306.59 (p < 0.001) among participants with asthma with income below 138% FPL after Medicaid expansion. The utilization and total cost of both short-acting bronchodilators and inhaled corticosteroids (ICSs) increased after Medicaid expansion among participants with asthma with incomes below 138% FPL. Among participants with uncontrolled asthma with incomes below 138% FPL, utilization and expenditures increased after Medicaid expansion for all asthma-related prescription drugs and short-acting bronchodilators.RESULTSUtilization of and total cost for asthma-related prescription drugs increased by 1.89 fills (p < 0.001) and $306.59 (p < 0.001) among participants with asthma with income below 138% FPL after Medicaid expansion. The utilization and total cost of both short-acting bronchodilators and inhaled corticosteroids (ICSs) increased after Medicaid expansion among participants with asthma with incomes below 138% FPL. Among participants with uncontrolled asthma with incomes below 138% FPL, utilization and expenditures increased after Medicaid expansion for all asthma-related prescription drugs and short-acting bronchodilators.Medicaid expansion was associated with increased utilization of and total expenditures for both quick-relief and preventive asthma medications among all low-income participants with asthma, but not with utilization of preventive medications among those with uncontrolled asthma.CONCLUSIONMedicaid expansion was associated with increased utilization of and total expenditures for both quick-relief and preventive asthma medications among all low-income participants with asthma, but not with utilization of preventive medications among those with uncontrolled asthma. |
| Author | Shi, Lu Li, Tao Ghanem, Buthainah Luck, Jeff |
| Author_xml | – sequence: 1 givenname: Lu orcidid: 0000-0002-1842-8334 surname: Shi fullname: Shi, Lu organization: College of Public Health and Human Sciences, Oregon State University – sequence: 2 givenname: Tao surname: Li fullname: Li, Tao organization: College of Public Health and Human Sciences, Oregon State University – sequence: 3 givenname: Jeff surname: Luck fullname: Luck, Jeff organization: College of Public Health and Human Sciences, Oregon State University – sequence: 4 givenname: Buthainah surname: Ghanem fullname: Ghanem, Buthainah organization: Department of Pharmaceutical Economics and Policy, School of Pharmacy, Chapman University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37171903$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUtv1DAUhS1URKcDPwHkJZsUP8bJjNhQVbykIjZlbd3Y1x2jxA62o6Es-eUkk5kNC9j4SkffOZbOuSIXIQYk5CVn15xt2RsmmobtmLwWTEyP4FJK_oSsuJKi2kgmL8hqZqoZuiRXOX9nbBJY_YxcyoY3fNJX5Pf9HulNztF4KD4GGh39gtYb8JbizwFCntWDL3s6JMwm-eHI2TQ-0LH4zv9ajBCOBgzWlzEhhT6GB9rFQ-WDiT3SAVLxxk-RJS-BkMu-h-fkqYMu44vTXZNvH97f336q7r5-_Hx7c1cZWdelMpbvlN0aVAJ2rt6AZNY6szGIiluBohHAHbhWNg5N3ezUpCnRSoXWti3KNXm95A4p_hgxF937bLDrIGAcsxZbLpWq5yLX5NUJHdserR6S7yE96nNvE_B2AUyKOSd02vhy7KEk8J3mTM8r6fNKel5Jn1aa3Oov9_mD__neLT4fXEw9HGLqrC7w2MXkEgTjs5b_jvgD36Gscw |
| CitedBy_id | crossref_primary_10_1080_02770903_2024_2412311 crossref_primary_10_1016_j_jaip_2024_06_008 crossref_primary_10_1136_thorax_2024_221778 |
| Cites_doi | 10.1056/NEJMsa1612890 10.1377/hlthaff.2015.1530 10.1513/AnnalsATS.201703-259OC 10.1159/000094898 10.1097/JOM.0b013e3181abb019 10.1377/hlthaff.2017.0830 10.1097/DCR.0000000000001260 10.7326/M18-2806 10.1016/j.ijrobp.2019.05.033 10.1111/1475-6773.13555 10.1377/hlthaff.2017.0925 10.1377/hlthaff.2018.0124 10.1002/hec.4155 10.1016/j.jaci.2007.09.029 10.1111/j.1398-9995.2006.01254.x 10.1377/hlthaff.2018.0154 10.1001/jamaoncol.2018.3467 10.1007/s40273-018-0726-2 10.1016/j.rmed.2017.08.014 10.1016/j.jaci.2010.10.020 10.1164/rccm.201901-0016OC 10.1097/MLR.0000000000001054 10.1016/j.jhealeco.2018.11.002 10.1016/j.annemergmed.2016.06.026 10.1377/hlthaff.2016.0091 10.2307/2137284 10.1001/jama.2014.2202 10.1016/j.jaci.2020.10.003 10.1111/j.1398-9995.2004.00526.x 10.1176/appi.ps.201800181 10.1093/cid/cix524 10.1016/j.jhealeco.2013.10.008 10.1016/0167-6296(82)90019-4 10.18553/jmcp.2017.23.3.355 10.3109/02770903.2014.906607 |
| ContentType | Journal Article |
| Copyright | 2023 Taylor & Francis Group, LLC 2023 |
| Copyright_xml | – notice: 2023 Taylor & Francis Group, LLC 2023 |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1080/02770903.2023.2213331 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-4303 |
| EndPage | 10 |
| ExternalDocumentID | 37171903 10_1080_02770903_2023_2213331 2213331 |
| Genre | Research Article Journal Article |
| GroupedDBID | --- 00X 03L 0R~ 29J 36B 4.4 5GY 5RE AAGDL AALUX AAMIU AAPUL AAQRR ABBKH ABEIZ ABIVO ABJNI ABLIJ ABLKL ABUPF ABWVI ABXYU ACENM ACGEJ ACGFO ACGFS ACIEZ ADCVX ADRBQ ADXPE AECIN AEGXH AENEX AEOZL AFKVX AFRVT AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE AQTUD BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EBS EJD F5P FEDTE H13 HVGLF HZ~ KRBQP KSSTO KWAYT KYCEM LJTGL M4Z O9- RNANH RVRKI SJN TASJS TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ UEQFS V1S ~1N AAYXX CITATION ADYSH NPM 7X8 |
| ID | FETCH-LOGICAL-c366t-cd195d8ce52a9f64a30ddfc4cee51d2e272a1fafb37fec67952e252b35eddbbe3 |
| IEDL.DBID | TFW |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000998336100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0277-0903 1532-4303 |
| IngestDate | Fri Sep 05 12:51:27 EDT 2025 Thu Apr 03 07:01:25 EDT 2025 Sat Nov 29 04:53:26 EST 2025 Tue Nov 18 21:47:12 EST 2025 Mon Oct 20 23:49:15 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | ahead-of-print |
| Keywords | uncontrolled asthma Affordable care act two-part models medical expenditure panel surveys preventive medication |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c366t-cd195d8ce52a9f64a30ddfc4cee51d2e272a1fafb37fec67952e252b35eddbbe3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-1842-8334 |
| PMID | 37171903 |
| PQID | 2813556133 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | crossref_primary_10_1080_02770903_2023_2213331 informaworld_taylorfrancis_310_1080_02770903_2023_2213331 pubmed_primary_37171903 proquest_miscellaneous_2813556133 crossref_citationtrail_10_1080_02770903_2023_2213331 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-11-02 |
| PublicationDateYYYYMMDD | 2023-11-02 |
| PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-02 day: 02 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | The Journal of asthma |
| PublicationTitleAlternate | J Asthma |
| PublicationYear | 2023 |
| Publisher | Taylor & Francis |
| Publisher_xml | – name: Taylor & Francis |
| References | e_1_3_2_28_1 e_1_3_2_49_1 e_1_3_2_20_1 e_1_3_2_41_1 e_1_3_2_22_1 e_1_3_2_43_1 e_1_3_2_24_1 e_1_3_2_45_1 e_1_3_2_26_1 e_1_3_2_39_1 e_1_3_2_9_1 e_1_3_2_18_1 e_1_3_2_7_1 e_1_3_2_10_1 e_1_3_2_33_1 e_1_3_2_52_1 e_1_3_2_12_1 e_1_3_2_35_1 e_1_3_2_5_1 e_1_3_2_14_1 e_1_3_2_37_1 e_1_3_2_50_1 e_1_3_2_27_1 e_1_3_2_29_1 National AE (e_1_3_2_3_1) 2007; 120 e_1_3_2_42_1 e_1_3_2_21_1 e_1_3_2_44_1 e_1_3_2_23_1 e_1_3_2_46_1 e_1_3_2_25_1 e_1_3_2_48_1 Yawn BP. (e_1_3_2_31_1) 2009; 11 Carrier E (e_1_3_2_40_1) 2014; 20 Elixhauser A (e_1_3_2_30_1) 1998; 3 Baxi SN (e_1_3_2_4_1) 2010; 21 e_1_3_2_17_1 e_1_3_2_38_1 e_1_3_2_8_1 e_1_3_2_19_1 e_1_3_2_2_1 e_1_3_2_11_1 e_1_3_2_32_1 e_1_3_2_6_1 e_1_3_2_13_1 e_1_3_2_34_1 e_1_3_2_15_1 e_1_3_2_36_1 Protection PA. (e_1_3_2_16_1) 2010; 111 e_1_3_2_51_1 |
| References_xml | – ident: e_1_3_2_43_1 doi: 10.1056/NEJMsa1612890 – ident: e_1_3_2_20_1 doi: 10.1377/hlthaff.2015.1530 – ident: e_1_3_2_36_1 – ident: e_1_3_2_52_1 doi: 10.1513/AnnalsATS.201703-259OC – ident: e_1_3_2_10_1 doi: 10.1159/000094898 – ident: e_1_3_2_12_1 doi: 10.1097/JOM.0b013e3181abb019 – ident: e_1_3_2_22_1 doi: 10.1377/hlthaff.2017.0830 – ident: e_1_3_2_50_1 doi: 10.1097/DCR.0000000000001260 – ident: e_1_3_2_18_1 doi: 10.7326/M18-2806 – ident: e_1_3_2_35_1 – ident: e_1_3_2_2_1 – ident: e_1_3_2_26_1 doi: 10.1016/j.ijrobp.2019.05.033 – ident: e_1_3_2_13_1 doi: 10.1111/1475-6773.13555 – ident: e_1_3_2_14_1 doi: 10.1377/hlthaff.2017.0925 – ident: e_1_3_2_23_1 doi: 10.1377/hlthaff.2018.0124 – ident: e_1_3_2_51_1 doi: 10.1002/hec.4155 – volume: 120 start-page: S94 issue: 5 year: 2007 ident: e_1_3_2_3_1 article-title: Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2007.09.029 – ident: e_1_3_2_6_1 – ident: e_1_3_2_11_1 doi: 10.1111/j.1398-9995.2006.01254.x – ident: e_1_3_2_46_1 doi: 10.1377/hlthaff.2018.0154 – ident: e_1_3_2_25_1 doi: 10.1001/jamaoncol.2018.3467 – ident: e_1_3_2_8_1 doi: 10.1007/s40273-018-0726-2 – ident: e_1_3_2_34_1 – volume: 11 start-page: 20 issue: 1 year: 2009 ident: e_1_3_2_31_1 article-title: Differential assessment and management of asthma vs chronic obstructive pulmonary disease publication-title: Medsc J Med – ident: e_1_3_2_49_1 doi: 10.1016/j.rmed.2017.08.014 – ident: e_1_3_2_41_1 doi: 10.1016/j.jaci.2010.10.020 – ident: e_1_3_2_29_1 – ident: e_1_3_2_37_1 – ident: e_1_3_2_33_1 doi: 10.1164/rccm.201901-0016OC – volume: 3 start-page: 98 year: 1998 ident: e_1_3_2_30_1 article-title: Clinical classifications for health policy research: hospital inpatient statistics, 1995. Healthcare cost and utilization project publication-title: HCUP – ident: e_1_3_2_39_1 – ident: e_1_3_2_45_1 doi: 10.1097/MLR.0000000000001054 – ident: e_1_3_2_21_1 doi: 10.1016/j.jhealeco.2018.11.002 – ident: e_1_3_2_17_1 doi: 10.1016/j.annemergmed.2016.06.026 – ident: e_1_3_2_19_1 doi: 10.1377/hlthaff.2016.0091 – ident: e_1_3_2_28_1 doi: 10.2307/2137284 – volume: 20 start-page: 925 issue: 11 year: 2014 ident: e_1_3_2_40_1 article-title: Medical cost burdens among nonelderly adults with asthma publication-title: Am J Manage Care – ident: e_1_3_2_42_1 doi: 10.1001/jama.2014.2202 – ident: e_1_3_2_48_1 doi: 10.1016/j.jaci.2020.10.003 – volume: 111 start-page: 759 issue: 48 year: 2010 ident: e_1_3_2_16_1 article-title: Affordable Care,. Patient protection and affordable care act publication-title: Public Law – ident: e_1_3_2_9_1 doi: 10.1111/j.1398-9995.2004.00526.x – ident: e_1_3_2_24_1 doi: 10.1176/appi.ps.201800181 – ident: e_1_3_2_5_1 doi: 10.1093/cid/cix524 – volume: 21 start-page: 57 issue: 1 year: 2010 ident: e_1_3_2_4_1 article-title: The role of allergen exposure and avoidance in asthma publication-title: Adolesc Med – ident: e_1_3_2_38_1 – ident: e_1_3_2_15_1 doi: 10.1016/j.jhealeco.2013.10.008 – ident: e_1_3_2_27_1 doi: 10.1016/0167-6296(82)90019-4 – ident: e_1_3_2_44_1 doi: 10.18553/jmcp.2017.23.3.355 – ident: e_1_3_2_7_1 – ident: e_1_3_2_32_1 doi: 10.3109/02770903.2014.906607 |
| SSID | ssj0002706 |
| Score | 2.3766932 |
| Snippet | This study estimated the association between the 2014 Medicaid expansion and asthma-related prescription drug utilization and expenditures among low-income... |
| SourceID | proquest pubmed crossref informaworld |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1 |
| SubjectTerms | Affordable care act medical expenditure panel surveys preventive medication two-part models uncontrolled asthma |
| Title | The Association of Medicaid expansion with prescription drug utilization and expenditure among low-income participants with asthma |
| URI | https://www.tandfonline.com/doi/abs/10.1080/02770903.2023.2213331 https://www.ncbi.nlm.nih.gov/pubmed/37171903 https://www.proquest.com/docview/2813556133 |
| Volume | ahead-of-print |
| WOSCitedRecordID | wos000998336100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAWR databaseName: Taylor & Francis customDbUrl: eissn: 1532-4303 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002706 issn: 0277-0903 databaseCode: TFW dateStart: 19810101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELYAIcTC-1EelZFYUxo7zmNEiIqFiqGIbpGfUKmkqEmBmV-Oz3GqMqAOMCbSOY59dz7f60PoMhLWRo2lDFgWsiBKVRJkqbK3VivkpiuYEVI4sImk30-Hw-zBZxOWPq0S7tCmbhThdDUINxdlkxF3BWFHcC90APq7Q4i9ZrlKamvZA48Pek9zXUwSh67pApVA0tTw_DbKj9PpR-_S3y1QdxL1tv_hH3bQljdD8XXNN7toRRd7aOPeB9r30ZdlH7ywdXhicB3TGSmsP60KAS8bBi8uhlTaRvdgNZ09Y8vMY1_fie0MgUBDaHw21dihG-Hx5COAvhCvGr9xn9ldVGU9IC-rl1d-gB57t4Obu8DDNQSSxnEVSBVmTKVSM8IzE0ecdpUyMrLHMAsV0SQhPDTcCJoYLeMkY_YdI4IyrZQQmh6itWJS6GOEBe-mEZdSEmoi1WU8FkZa00zEYOBEcQtFzTbl0vcyB0iNcR42LU_9-uawvrlf3xbqzMne6mYeywiyRR7IK-dFMTXkSU6X0F40DJNbkYU4DC_0ZFbmJA0poJJS2kJHNSfNp0Pt9draaPTkD18-RZvw6ComyRlaq6YzfY7W5Xs1KqdttJoM07YTk2-R_w8W |
| linkProvider | Taylor & Francis |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR25TsMw1EKAgIX7KKeRWFMaO84xIkQFonQqgs3yCUglrdoUmPly_JykKgNigDXRcxz73SdCZ5F0OmqsVMCykAVRqpMgS7WzWh2R25ZkVirph00k3W76-JjN1sJAWiXY0LZsFOF5NRA3OKPrlLhziDuCf6EJs7-bhDg7C0qpF5iTtZDW12s_TLkxSfx8TR-qBJi6iuenZb7Jp2_dS3_WQb0saq_9x1-so9VKE8UXJepsoDmTb6KluyrWvoU-HQbhmdvDA4vLsM6LxubDcRFwtGFw5GLIpq3ZD9ajyRN2-NyvSjyx2yIAGIiOT0YG-wFHuD94D6A1xKvBQ1Eld-fFuFxQjIvnV7GN7ttXvcvroJrYECgax0WgdJgxnSrDiMhsHAna0tqqyEliFmpiSEJEaIWVNLFGxUnG3DNGJGVGaykN3UHz-SA3ewhL0UojoZQi1Ea6xUQsrXLamYxBx4niBorqe-KqamcOUzX6PKy7nlbny-F8eXW-DdScgg3Lfh6_AWSzSMAL70ix5dQTTn-BPa0xhjuqhVCMyM1gMuYkDSkMJqW0gXZLVJpuhzoL26lpdP8PXz5By9e9uw7v3HRvD9AKvPIFlOQQzRejiTlCi-qteBmPjj21fAEuAxJP |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQgiouu8tzuyxgJK4pjR3ncURABQKqHorozfJzqdSmVZLu7nl_OR7HqdpD1QNcE43j2DPj8bw-hN4n0tmoqVIRK2IWJbnOoiLX7tbqhNwOJbNSSQ82kY3H-WxWTEI2YR3SKuEObdtGEV5Xg3Cvte0y4j5A2BHcCwOA_h4Q4q5ZUEn90DfHciw9Hf3eKmOSeXhNH6kEmq6I59Awe8fTXvPSwyaoP4pGZ__hJ87RabBD8ceWcZ6gB6Z8ino_Q6T9Gbp3_IN39g6vLG6DOnONzZ3TIeBmw-DGxZBL2ykfrKvNNXbcvAgFntjNEAgMxMY3lcEe3ggvVrcRNIZYGrwWIbW7bOp2QFE3f5biOfo1-jL99DUKeA2RomnaRErHBdO5MoyIwqaJoEOtrUrcOcxiTQzJiIitsJJm1qg0K5h7xoikzGgtpaEv0Em5Ks0FwlIM80QopQi1iR4ykUqrnG0mU7BwkrSPkm6buArNzAFTY8HjrudpWF8O68vD-vbRYEu2brt5HCModnmAN96NYlvME06P0L7rGIY7mYVAjCjNalNzkscUYEkp7aOXLSdtp0Pd_doZafTyH778FvUmn0f8x7fx91foMbzx1ZPkCp001ca8Ro_UTTOvqzdeVv4Ct9kQ8w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Association+of+Medicaid+expansion+with+prescription+drug+utilization+and+expenditure+among+low-income+participants+with+asthma&rft.jtitle=The+Journal+of+asthma&rft.au=Shi%2C+Lu&rft.au=Li%2C+Tao&rft.au=Luck%2C+Jeff&rft.au=Ghanem%2C+Buthainah&rft.date=2023-11-02&rft.eissn=1532-4303&rft.spage=1&rft_id=info:doi/10.1080%2F02770903.2023.2213331&rft_id=info%3Apmid%2F37171903&rft.externalDocID=37171903 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-0903&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-0903&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-0903&client=summon |